| Quality of Sexual Function in BRCA Mutated Women (NCT05456919) | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | 2022-07-15 |
| Early Psychological Intervention After Rape (NCT05489133) | St. Olavs Hospital | 2022-06-14 |
| Internet-based Emotion Regulation Intervention for Sexual Health (NCT04792177) | University of Luxembourg | 2021-05-05 |
| Sexual Function Changes in High-Risk Pregnancies (NCT05093647) | Saglik Bilimleri Universitesi | 2021-04-15 |
| Study of Pharmacological Treatment in Women With Female Sexual Interest/Arousal Disorder (FSIAD). (NCT04433559) | Lidia Larrañaga | 2020-08-01 |
| Mindfulness as Treatment of Sexological Problems (NCT03775239) | Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital | 2018-07-25 |
| Innovations in the Treatment of Sexual Health Post Prostate Cancer Treatment: Comparing Mindfulness vs. CBT (NCT03365518) | University of British Columbia | 2017-12-29 |
| Bupropion in Sexual Dysfunction Among Methadone Maintenance Treatment Men (NCT02593396) | University of Malaya | 2015-12-01 |
| Sexual Function in Patients Suspected of Non-muscle Invasive Bladder Cancer (NCT02381912) | Herlev Hospital | 2015-03-01 |
| A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer (NCT01654458) | Women's College Hospital | 2012-07-01 |
| Sexual Health on Antidepressants Through Physical Exercise (NCT01188720) | University of Texas at Austin | 2010-11-01 |
| Pharmacokinetics of Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder (HSDD) (NCT01188603) | Sprout Pharmaceuticals, Inc | 2010-07-01 |
| A 28-week Safety Study of Flibanserin in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder (NCT01103362) | Sprout Pharmaceuticals, Inc | 2010-04-01 |
| 12 Week Safety Trial of Flibanserin in Depressed Women Taking an SSRI or SNRI With Decreased Sexual Desire and Distress (NCT01040208) | Sprout Pharmaceuticals, Inc | 2010-01-01 |
| Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women (NCT00996372) | Sprout Pharmaceuticals, Inc | 2009-10-01 |
| Fixed 100 mg Every Evening of Flibanserin vs Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder (NCT00996164) | Sprout Pharmaceuticals, Inc | 2009-10-01 |
| Flibanserin Evaluation Over 28 Additional Weeks in Hypoactive Sexual Desire Disorder (NCT00601367) | Sprout Pharmaceuticals, Inc | 2008-01-01 |
| HIV Prevention Among Vulnerable Male Youth (NCT01771237) | Ann & Robert H Lurie Children's Hospital of Chicago | 2007-07-01 |
| Flibanserin Versus Placebo in Premenopausal Women With HSDD (NCT00491829) | Sprout Pharmaceuticals, Inc | 2007-06-01 |
| A One-year Safety Study of Flibanserin to Treat Pre-Menopausal Women With Hypoactive Sexual Desire Disorder (HSDD). (NCT00441558) | Sprout Pharmaceuticals, Inc | 2007-02-01 |
| Uptitration Trial of Flibanserin Versus Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder (NCT00360555) | Sprout Pharmaceuticals, Inc | 2006-07-01 |
| 6-mo. Min Eff Dose of Flibanserin: 25 v 50 mg Bid v 50 mg hs v Pbo in Younger Women in NA (NCT00360243) | Sprout Pharmaceuticals, Inc | 2006-07-01 |
| 24-week Placebo-controlled Trial of Flibanserin Once Daily in Premenopausal Women With Hypoactive Sexual Desire Disorder (NCT00360529) | Sprout Pharmaceuticals, Inc | 2006-07-01 |
| Flibanserin Randomized Withdrawal Trial in Pre-menopausal Women (NCT00277914) | Sprout Pharmaceuticals, Inc | 2006-01-01 |
| Group Psychoeducational Treatment for Women With Sexual Arousal Difficulties (NCT00175539) | University of British Columbia | 2005-11-01 |
| Cervical or Endometrial Cancer and Sexual Health Study (NCT00134316) | University of British Columbia | 2005-08-01 |
| Female Sexual Dysfunction: Prevalence Among Italian Healthy Women (NCT00148200) | Unita Complessa di Ostetricia e Ginecologia | 2005-02-01 |
| An Open-Label, Extension Study Evaluating the Safety, Toleration, and Efficacy of Sildenafil in Women With Sexual Arousal Disorder (NCT00746967) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2003-01-01 |
| Ginkgo Biloba: Antidepressant-Induced Sexual Dysfunction (NCT00034021) | National Center for Complementary and Integrative Health (NCCIH) | 2002-06-01 |